Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
163222-33-1
Purity
95%
Ezetimibe is a lipid-lowering compound that inhibits intestinal cholesterol and phytosterol absorption. The primary target of ezetimibe is the cholesterol transport protein Niemann-Pick C1-Like 1 (NPC1L1) protein. Ezetimibe is indicated to reduce elevated total-C, LDL-C, Apo B, and non-HDL-C in patients with primary hyperlipidemia, alone or in combination with an HMG-CoA reductase inhibitor.
Properties
Name
Ezetimibe
Smiles
O[C@@H](CC[C@@H]1[C@H](N(C1=O)C=2C=CC(F)=CC2)C=3C=CC(O)=CC3)C=4C=CC(F)=CC4
Targets
Please log in to see this information
Impurity
SDS
EZE | Ezetimibe | Ezetrol | SCH58235 | Zetia | ezetemibe | ezetimib
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$19
2 mg
$19
5 mg
$19
10 mg
$19
15 mg
$19
20 mg
$19
25 mg
$19
30 mg
$19
35 mg
$19
40 mg
$19
45 mg
$19
50 mg
$19
75 mg
$19
100 mg
$POA
Quantity
1
Total amount
$ 19
EZE | Ezetimibe | Ezetrol | SCH58235 | Zetia | ezetemibe | ezetimib
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.